Leukaemias and Lymphomas

Abstract

The leukaemias and lymphomas are neoplastic diseases of the blood and blood‐forming organs that are highly treatable and often curable. They cause bone marrow and immune system dysfunction, which renders the host highly susceptible to infection and bleeding. Often organ dysfunction secondary to tumour cell infiltration or tumour compression of vital structures may be apparent clinically. Tumour formation and organomegaly are more common with the lymphomas than with leukaemias.

Keywords: haematology; oncology; cancer treatment

References

Damle RN, Wasil T, Fais Fet al.(1999) Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 94: 1840–1847.

Dearden CE, Matutes E, Hilditch BL et al. (1999) Long‐term follow‐up of patients with hairy cell leukaemia after treatment with pentostatin or cladribine. British Journal of Haematology 106: 515–519.

Druker BJ and Lydon NB (2000) Lessons learned from the development of an abl tyrosine kinase inhibitor for chronic myelogenous leukemia. Journal of Clinical Investigation 105: 3–7.

Griesinger F, Piro‐Noack M, Kaib N et al. (1999) Leukaemia‐associated immunophenotypes (LAIP) are observed in 90% of adult and childhood acute lymphoblastic leukaemia: detection in remission marrow predicts outcome. British Journal of Haematology 105: 241–255.

Hartmann JT, Nichols CR, Droz J‐P et al. (2000) Hematologic disorders associated with primary mediastinal nonseminomatous germ cell tumors. Journal of the National Cancer Institute 92: 54–61.

Jing Y, Dai J, Chalmers‐Redman RME et al. (1999) Arsenic trioxide selectively induces acute promyelocytic leukemia cell apoptosis via a hydrogen peroxide‐dependent pathway. Blood 94: 2102–2111.

Jungnickel B, Staratschek‐Jox A, Brauninger A et al. (2000) Clonal deleterious mutations in the IκB alpha gene in the malignant cells of Hodgkin's lymphoma. Journal of Experimental Medicine 191: 395–401.

Krajinovic M, Labuda D, Richer C et al. (1999) Susceptibility to childhood acute lymphoblastic leukemia: influence of CYP1A1, CVP2D6, GSTM1 and GSTT2 genetic polymorphisms. Blood 93: 1496–1501.

Panzer‐Grumayer ER, Schneider M, Panzer S et al. (2000) Rapid molecular response during early induction chemotherapy predicts a good outcome in childhood acute lymphoblastic leukemia. Blood 95: 790–794.

Sinclair PB, Nacheva EP, Leversha M et al. (2000) Large deletions at the t(9;22) breakpoint are common and may identify a poor‐prognosis subgroup of patients with chronic myeloid leukemia. Blood 95: 738–744.

Thieblemont C, Berger F, Dumont C et al. (2000) Mucosa‐associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed. Blood 95: 802–806.

Tobal K, Newton J, Macheta M et al. (2000) Molecular quantitation of minimal residual disease in acute myeloid leukemia with t(8;21) can identify patients in durable remission and predict clinical relapse. Blood 95: 815–819.

Wetzler M, Dodge RK, Mrozek K et al. (1999) Prospective karyotype analysis in adult acute lymphoblastic leukemia: the Cancer and Leukemia Group B experience. Blood 93: 3983–3993.

Wiernik PH, Wang SQ, Hu X‐P, Marino P and Paietta E (2000) Age of onset evidence for anticipation in familial non‐Hodgkin's lymphoma. British Journal of Haematology 108: 72–79.

Wiernik PH, Ashwin M, Hu X‐P, Paietta E and Brown K (2001) Anticipation in familial chronic lymphocytic leukaemia. British Journal of Haematology 113: 407–414.

Further Reading

Hoffman R, Benz EJ Jr and Shattil SJ et al. (2000) Hematology: Basic Principles and Practice, 3rd edn. New York: Churchill Livingstone.

Lee RG, Foerster J and Lukens J et al. (1999) Wintrobe's Clinical Hematology, 10th edn. Philadelphia, PA: Lippincott Williams and Wilkins.

Pevkham M, Pinedo HM and Veronesi U (1995) Oxford Textbook of Oncology. Oxford, UK: Oxford University Press.

Wiernik PH, Dutcher JP, Goldman JM and Kyle RA (2003) Neoplastic Diseases of the Blood. London: Cambridge University Press.

Contact Editor close
Submit a note to the editor about this article by filling in the form below.

* Required Field

How to Cite close
Wiernik, Peter H(May 2005) Leukaemias and Lymphomas. In: eLS. John Wiley & Sons Ltd, Chichester. http://www.els.net [doi: 10.1038/npg.els.0003857]